A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2024

Primary Completion Date

November 18, 2024

Study Completion Date

August 31, 2025

Conditions

Obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893

Trial Locations (1)

Fuwai Hospital Chinese Academy of Medical Sciences (CAMS), Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06516068 - A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter